Loading
Latest filing published 20 Aug 2023 for Eupraxia Pharmaceuticals Inc..
No signal scores available.
Mark Marion Kowalski discloses dealings in Eupraxia Pharmaceuticals Inc. to SEDI. In total, 2 filings cover trades dated from 18 May 2023 to 18 August 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 20 August 2023, reports a transaction in Eupraxia Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations